Pharma sector to remain a market favourite due to earnings visibility, say analysts

The sector will remain a market favourite due to earnings visibility, which does not exist for most sectors currently because of the pandemic. Analysts said there is potential for earnings to double in the next five years.

from Stocks-Markets-Economic Times https://ift.tt/2H6DCnM